A detailed history of Acadian Asset Management LLC transactions in Enanta Pharmaceuticals Inc stock. As of the latest transaction made, Acadian Asset Management LLC holds 849,424 shares of ENTA stock, worth $8.6 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
849,424
Previous 849,424 -0.0%
Holding current value
$8.6 Million
Previous $11 Million 20.14%
% of portfolio
0.03%
Previous 0.03%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 06, 2024

SELL
$11.43 - $17.02 $51,114 - $76,113
-4,472 Reduced 0.52%
849,424 $11 Million
Q1 2024

May 10, 2024

BUY
$10.08 - $17.46 $110,396 - $191,221
10,952 Added 1.3%
853,896 $14.9 Million
Q4 2023

Feb 13, 2024

BUY
$8.18 - $10.78 $2.41 Million - $3.17 Million
294,162 Added 53.6%
842,944 $7.93 Million
Q3 2023

Nov 13, 2023

BUY
$11.09 - $22.13 $4.97 Million - $9.92 Million
448,201 Added 445.61%
548,782 $6.13 Million
Q2 2023

Aug 07, 2023

BUY
$20.68 - $39.85 $2.08 Million - $4.01 Million
100,581 New
100,581 $2.15 Million
Q2 2022

Aug 09, 2022

SELL
$38.13 - $76.93 $1.11 Million - $2.24 Million
-29,133 Reduced 40.59%
42,640 $2.02 Million
Q1 2022

May 12, 2022

SELL
$56.06 - $74.11 $3.41 Million - $4.5 Million
-60,754 Reduced 45.84%
71,773 $5.1 Million
Q4 2021

Feb 10, 2022

SELL
$60.19 - $97.37 $6.39 Million - $10.3 Million
-106,113 Reduced 44.47%
132,527 $9.9 Million
Q3 2021

Nov 12, 2021

SELL
$41.02 - $58.65 $5.27 Million - $7.53 Million
-128,372 Reduced 34.98%
238,640 $13.5 Million
Q2 2021

Aug 11, 2021

SELL
$43.76 - $53.11 $4.23 Million - $5.14 Million
-96,762 Reduced 20.86%
367,012 $16.2 Million
Q1 2021

May 11, 2021

SELL
$41.69 - $54.95 $155,920 - $205,513
-3,740 Reduced 0.8%
463,774 $22.9 Million
Q4 2020

Feb 11, 2021

SELL
$41.16 - $47.47 $65,897 - $75,999
-1,601 Reduced 0.34%
467,514 $19.7 Million
Q3 2020

Nov 09, 2020

BUY
$43.36 - $53.53 $2.42 Million - $2.98 Million
55,730 Added 13.48%
469,115 $21.5 Million
Q2 2020

Aug 12, 2020

BUY
$46.37 - $57.58 $3.22 Million - $4 Million
69,503 Added 20.21%
413,385 $20.8 Million
Q1 2020

May 11, 2020

SELL
$40.22 - $62.0 $22,844 - $35,216
-568 Reduced 0.16%
343,882 $17.7 Million
Q4 2019

Feb 06, 2020

BUY
$57.95 - $66.61 $261,412 - $300,477
4,511 Added 1.33%
344,450 $21.3 Million
Q3 2019

Nov 07, 2019

SELL
$60.08 - $88.17 $3.93 Million - $5.76 Million
-65,330 Reduced 16.12%
339,939 $20.4 Million
Q2 2019

Aug 08, 2019

BUY
$81.3 - $97.35 $1.2 Million - $1.44 Million
14,793 Added 3.79%
405,269 $34.2 Million
Q1 2019

May 09, 2019

BUY
$69.08 - $105.66 $3 Million - $4.59 Million
43,472 Added 12.53%
390,476 $37.3 Million
Q4 2018

Feb 07, 2019

SELL
$65.41 - $84.65 $6.52 Million - $8.44 Million
-99,671 Reduced 22.31%
347,004 $24.6 Million
Q3 2018

Oct 30, 2018

BUY
$85.46 - $126.37 $5.55 Million - $8.21 Million
64,946 Added 17.01%
446,675 $38.2 Million
Q2 2018

Jul 24, 2018

BUY
$81.85 - $120.51 $13.1 Million - $19.3 Million
160,344 Added 72.43%
381,729 $44.2 Million
Q1 2018

Apr 12, 2018

BUY
$57.91 - $92.15 $11.3 Million - $18.1 Million
195,896 Added 768.55%
221,385 $17.9 Million
Q4 2017

Jan 18, 2018

BUY
$45.65 - $59.37 $1.16 Million - $1.51 Million
25,489
25,489 $1.5 Million

Others Institutions Holding ENTA

About ENANTA PHARMACEUTICALS INC


  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $210M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track Acadian Asset Management LLC Portfolio

Follow Acadian Asset Management LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Acadian Asset Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Acadian Asset Management LLC with notifications on news.